Steptoe & Johnson announced that antitrust and competition lawyer Damon Kalt has returned to the firm as a partner in its Washington office.
Kalt most recently served as senior counsel for antitrust and competition at Cigna Corporation, where he played a key role in securing the Department of Justice’s (DOJ) clearance of Cigna’s $67 billion acquisition of pharmacy benefits manager Express Scripts.
During his tenure with Cigna, Kalt advised on antitrust and competition law-related issues across the company’s various lines of business including medical, pharmacy, Medicare and Medicaid. Kalt served as the primary internal counsel for all antitrust and competition aspects of Cigna’s acquisition of Express Scripts, a vertical transaction that the DOJ approved unconditionally in September 2018.
Full Content: Steptoe & Johnson
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Athletes File New Objections to NCAA’s $2.8 Billion Settlement Proposal
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas